TreVia’s diabetes SmartCare™ experience will be the first diabetes platform solution with clinical workflow that integrates peripheral neuropathy screening using the Prosenex device to deliver objective measurements for early and better detection of neuropathy to prevent limb loss, reduce health care costs and sustain a higher quality of life for pre diabetics and diabetics.
(PRWeb November 16, 2015)
Read the full story at http://www.prweb.com/releases/2015/11/prweb13081763.htm
For more information, please visit
http://www.prweb.com/releases/2015/11/prweb13081763.htm